Delivering Double-Digit Pharmacy Savings: A Case Study

April 30, 2020

With rising growth projections on top of already high costs, it’s no wonder that plan sponsors are looking for ways to reduce expenses and improve member health.

The National Business Group on Health (NBGH) recently conducted a study that included responses from 147 large employers, who represent over 15.6 million employees and their dependents. Of these, 54 percent were Fortune 500 companies and 39 of them were Fortune 100.1 The survey found that “for 85 percent of employers, pharmacy pricing was their predominant concern going into 2020.”1

If you’re like these employers, you may be seeking an alternative solution to help you take the unnecessary costs out of pharmacy benefits and make prescriptions more affordable for you and your members. Find out how one electric utility cooperative was able to achieve double-digit plan and member savings in the first-year by switching to a transformative pass-through model.

IMPROVING EFFICIENCIES WITH A MEDICARE WRAP

Prior to Navitus, Kentucky Rural Electric Cooperative (KREC) populations had two separate pharmacy networks and benefit plans, causing confusion and disruption. Retirees used two different PBM benefit cards to pay for their prescriptions and pharmacies had to adjudicate each claim twice, once for each plan. Working closely with KREC, Navitus designed a wrap solution that applied the same national network to both populations and provided for single-point claim adjudication and plan administration.

REDUCING COSTS THROUGH FORMULARY MANAGEMENT

In addition to a self-funded Medicare wrap, a second cost reduction opportunity was identified in KREC’s formulary management. Instead of using a common formulary that prioritized rebates above all else, KREC chose to switch to a well-managed formulary that prioritized the lowest-net cost without compromising access to clinically effective medications. Then they supported the formulary with a comprehensive suite of utilization management tools, including prior authorization, step therapy and quantity limits.

REALIZING PLAN AND MEMBER SAVINGS

The collaboration between KREC and Navitus yielded impressive first-year results, including a 29% decrease in plan costs. These savings benefited not only the plan, but its members, too.

Want to see the results?

Learn more about KREC’s journey to finding a PBM partner that was able to tailor its program to the specific needs of both the plan and its members, while delivering impressive real results.

With a member population that includes retirees on the Medicare Part D prescription drug benefit, KREC wanted to take control of its costs for both the plan and its members by eliminating ancillary expenses that didn’t benefit members. The plan also wanted to tailor its pharmacy benefits to better serve its retiree population and to improve member health.

To accomplish this, KREC reevaluated its traditional pharmacy
benefit manager (PBM) and decided to seek a fully-transparent
PBM that could develop solutions customized to its population
and enable greater cost management.

Download the FULL case study to learn more.

The collaboration between KREC and Navitus yielded impressive results, including $1.3 million in first-year savings, a 29% reduction compared to the previous year.

Waddill, K. Employers Focus on High-Cost Claims, Drug Spending into 2020. Health Payer Intelligence. https://healthpayerintelligence.com/news/employers-focus-on-high-cost-claims-drug-spending-into-2020. Published August 15, 2019. Accessed February 12, 2020.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

In this overview of our national Legal Ease webinar event, we highlight key federal and state developments shaping the conversation around PBM reform – and what they mean for your clients.  …

Navigating the Drug Supply Chain: What You Need to Know

Navigating the Drug Supply Chain: What You Need to Know

Before a prescription ever reaches a pharmacy counter, it has already moved through a complex ecosystem known as the drug supply chain. From manufacturers and wholesalers to pharmacy benefit managers (PBMs) and pharmacies, each entity plays a role in…

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

previous arrow
next arrow